Your browser doesn't support javascript.
loading
Medical hypnosis mitigates laboratory dyspnoea in healthy humans: a randomised, controlled experimental trial.
Morélot-Panzini, Capucine; Arveiller-Carvallo, Cécile; Rivals, Isabelle; Wattiez, Nicolas; Lavault, Sophie; Brion, Agnès; Serresse, Laure; Straus, Christian; Niérat, Marie-Cécile; Similowski, Thomas.
Afiliação
  • Morélot-Panzini C; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France capucine.morelot@aphp.fr.
  • Arveiller-Carvallo C; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service de Pneumologie (Département R3S), Paris, France.
  • Rivals I; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Wattiez N; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Lavault S; Université Paris, Sciences, Lettres; ESPCI; Equipe de Statistique Appliquée, ESPCI, Paris, France.
  • Brion A; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Serresse L; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Straus C; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service de Médecine de Réadaptation Respiratoire (Département R3S), Paris, France.
  • Niérat MC; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Service des Pathologies du Sommeil (Département R3S), Paris, France.
  • Similowski T; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
Eur Respir J ; 2024 Jul 26.
Article em En | MEDLINE | ID: mdl-38991710
ABSTRACT
QUESTION Dyspnoea persisting despite treatments of underlying causes requires symptomatic approaches. Medical hypnosis could provide relief without the untoward effects of pharmacological approaches. We addressed this question through experimentally induced dyspnoea in healthy humans (inspiratory threshold loading -excessive inspiratory effort- and carbon dioxide stimulation -air hunger-) MATERIAL AND

METHODS:

20 volunteers (10 women, 21-40) were studied on 4 separate days. The order of the visits was randomised in two steps, firstly "inspiratory threshold loading first" versus "carbon dioxide first" group (n=10 in each group), secondly "medical hypnosis first" versus "visual distraction first" subgroup (n=5 in each subgroup). Each visit comprised three 5-minutes periods (reference, intervention, washout) during which participants used visual analog scales to rate dyspnoea's sensory and affective dimensions and after which they completed the Multidimensional Dyspnea Profile.

RESULTS:

Medical hypnosis reduced both dimensions of dyspnoea significantly more than visual distraction (inspiratory threshold loading sensory reduction after 5 min 34% of full VAS versus 8% -p=0.0042-; affective reduction 17.6% versus 2.4% -p=0.044-; carbon dioxide; sensory reduction after 5 min 36.9% versus 3% -p=0.0015-; affective reduction 29.1% versus 8.7% -p=0.0023-). The Multidimensional Dyspnea Profile showed more marked sensory effects during inspiratory threshold loading and more marked affective effects during carbon dioxide stimulation. ANSWER TO THE QUESTION Medical hypnosis was more effective than visual distraction at attenuating the sensory and affective dimensions of experimentally induced dyspnoea. This provides a strong rationale for clinical studies of hypnosis in persistent dyspnoea patients.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Eur Respir J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Eur Respir J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França